Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis

Journal of Neuroimmunology

Volumn 84, Issue 2, 1998, Pages 179-187

  Sellebjerg, Finn ^a   Jensen, Jakob ^a   Ryder, Lars P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acute optic neuritis; CD80; CD86; Cerebrospinal fluid; Multiple sclerosis

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DEMYELINATING DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032522185     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00261-0     Document Type: Article

References (59)

1. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L.L.et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 366:1993;76-79.
2. Azuma M., Yssel H., Phillips J.H., Spits H., Lanier L.L. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:1993;845-850.
3. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., Lindsten T.et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity. 3:1995;87-98.
4. Chambers C.A., Allison J.P. Costimulation in T cell responses. Curr. Opin. Immunol. 9:1997;396-404.
5. Chowdbury M.G.M., Maeda K.-I., Yasutomo K., Maekawa Y., Furukawa A., Azuma M.et al. Antigen-specific B cells are required for the secondary response of T cells but not for their priming. Eur. J. Immunol. 26:1996;1628-1633.
6. + T cells. J. Immunol. 154:1995;4915-4923.
7. + T cells to protein antigens in vivo. J. Immunol. 155:1995;3734-3741.
8. Dangond F., Windhagen A., Groves C.J., Hafler D.A. Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J. Neuroimmunol. 76:1997;132-138.
9. De Simone R., Giampaolo A., Giometto B., Gallo P., Levi G., Peschle C.et al. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54:1995;175-187.
10. Dux R., Kindler-Röhrborn A., Annas M., Faustmann P., Lennartz K., Zimmermann C.W. A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluid. J. Neurol. Sci. 121:1994;74-78.
11. Ford A.L., Goodsall A.L., Hickey W.F., Sedgwick W.F. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. J. Immunol. 154:1995;4309-4321.
12. Fraser J.D., Irving B.A., Crabtree G.R., Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science. 251:1991;313-316.
13. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G.M., Ke X.Y., Rennert P.D.et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:1995;523-532.
14. Gausas J., Paterson P.Y., Day E.D., Dal Canto M.C. Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats. Cell. Immunol. 72:1982;360-366.
15. + B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J. Clin. Invest. 99:1997;2664-2671.
16. Gerritse K., Deen C., Fasbender M., Ravid R., Boersma W., Claassen E. The involvement of specific anti myelin basic protein antibody-forming cells in multiple sclerosis immunopathology. J. Neuroimmunol. 49:1994;153-159.
17. Greenfield E.A., Howard E., Paradis T., Nguyen K., Benazzo F., McLean P.et al. B7-2 expressed on T cells does not induce CD28-mediated costimulatory activity: implications for antitumor immunity to T cell tumors. J. Immunol. 158:1997;2025-2034.
18. Gribben J.G., Freeman G.J., Boussiotis V.A., Rennert P., Jellis C.L., Greenfield E.et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl. Acad. Sci. U.S.A. 92:1995;811-815.
19. Gross H.-J., Verwer B., Houck D., Recktenwald D. Detection of rare cells at a frequency of one per million by flow cytometry. Cytometry. 14:1993;519-526.
20. Harling-Berg C.J., Knopf P.M., Cserr H.F. Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitis. J. Neuroimmunol. 35:1991;45-51.
21. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 239:1988;290-292.
22. Hirokawa M., Kitabayashi A., Kuroki J., Miura A.B. Signal transduction by B7/BB1 expressed on activated T lymphocytes: cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3. Immunology. 86:1995;155-161.
23. Jacobs L.D., Kaba S.E., Miller C.M., Priore R.L., Brownscheidle C.M. Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann. Neurol. 41:1997;392-398.
24. Karandikar N.J., Vanderlugt C.L., Walunas T.L., Miller S.D., Bluestone J.A. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:1996;783-788.
25. Krummel M.F., Allison J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:1995;459-465.
26. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A.et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
27. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
28. Lin R.-H., Mamula M.J., Hardin J.A., Janeway C.A. Induction of autoreactive B cells allows priming of autoreactive T cells. J. Exp. Med. 173:1991;1433-1439.
29. Lindsten T., June C.H., Ledbetter J.A., Stella G., Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science. 244:1989;339-343.
30. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721-730.
31. Mamula M.J., Fatenajad S., Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152:1994;1453-1461.
32. Manengére L.E.M., Waterhouse P., Duncan G.S., Mittrücker H.-W., Feng G.-S., Mak T.W. Regulation of T cell receptor signalling by tyrosine phosphatase SYP association with CTLA-4. Science. 272:1996;1170-1173.
33. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:1994;991-1045.
34. + T cells: I. Involvement of the CD80-CD28 adhesion molecules. J. Immunol. 155:1995;118-127.
35. Merelli E., Sola P., Faglioni P., Giordani S., Mussini D., Montagnani G. Natural killer cells and lymphocyte subsets in active MS and acute inflammation of the CNS. Acta Neurol. Scand. 84:1991;127-131.
36. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C.et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:1995;739-745.
37. Miller D.J., Njenga M.K., Parisi J.E., Rodriguez M. Multi-organ reactivity of a monoclonal natural autoantibody that promotes remyelination in a mouse model of multiple sclerosis. J. Histochem. Cytochem. 44:1996;1005-1011.
38. Myers K.J., Sprent J., Dougherty J.P., Ron Y. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 41:1992;1-8.
39. Paolino E., Fainardi E., Ruppi P., Tola M.R., Govoni V., Casetta I.et al. A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 60:1996;572-575.
40. Perrin P.J., Maldonado J.H., Davis T.A., June C.H., Racke M.K. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 157:1996;1333-1336.
41. Perrin P.J., Scott D., Davis T.A., Gray G.S., Doggett J.J., Abe R.et al. Opposing effects of CTLA-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis. J. Neuroimmunol. 65:1996;31-39.
42. Piddlesden S.J., Lassmann H., Zimprich F., Morgan B.P., Linington C. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143:1993;555-564.
43. Poser C.M. Onset symptoms of multiple sclerosis [letter]. J. Neurol. Neurosurg. Psychiatry. 58:1995;254-255.
44. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C.et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
45. Prabhu Das M.R., Zamvil S.S., Borriello F., Weiner H.L., Sharpe A.H., Kuchroo V.K. Reciprocal expression of costimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur. J. Immunol. 25:1995;207-211.
46. Racke M.K., Scott D.E., Quigley L., Gray G.S., Abe R., June C.H.et al. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:1995;2195-2203.
47. Sellebjerg F., Christiansen M. Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement. Scand. J. Clin. Lab. Invest. 56:1996;135-143.
48. Sellebjerg F.T., Frederiksen J.L., Olsson T. Anti-myelin basic protein and anti-proteolipid protein antibody-secreting cells in the cerebrospinal fluid of patients with acute optic neuritis. Arch. Neurol. 51:1994;1032-1036.
49. Sellebjerg F., Frederiksen J.L., Olsson T., Link H., Madsen H.O., Ryder L.P.et al. Peptide specificity of anti-myelin basic protein antibodies in patients with acute optic neuritis and the HLA system. Scand. J. Immunol. 39:1994;575-580.
50. Sellebjerg F., Madsen H.O., Frederiksen J.L., Ryder L.P., Svejgaard A. Acute optic neuritis: myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system. Ann. Neurol. 38:1995;943-950.
51. Sharief M.K., Thompson E.J. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann. Neurol. 29:1991;147-151.
52. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
53. Svenningsson A., Andersen O., Edsbagge M., Stemme S. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J. Neuroimmunol. 63:1995;39-46.
54. Svenningson A., Dotevall L., Stemme S., Andersen O. Increased expression of B7-1 costimulatory molecule on cerebrospinal fluid cells of patients with multiple sclerosis and infectious central nervous system disease. J. Neuroimmunol. 75:1997;75-83.
55. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., Sharpe A.H. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:1995;541-547.
56. Williams K., Ulvestad E., Antel J.P. B7/BB1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:1994;3031-3037.
57. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L.et al. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.
58. Wold S.D., Dittel B.N., Hardardottir F., Janeway C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:1996;2271-2278.
59. Wu Y., Guo Y., Huang A., Zheng P., Liu Y. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J. Exp. Med. 185:1997;1327-1335.